Life Technologies Signs Licensing Agreement with iPS Academia Japan

News   Jun 18, 2012

 
Life Technologies Signs Licensing Agreement with iPS Academia Japan
 
 
 

RELATED ARTICLES

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

Novel Scaffolds to Grow Muscle Developed

News

RMIT biomedical engineers have successfully produced a 3D material that mimics nature to transform cells into muscle.

READ MORE

Studying Ebola-Host Cell Interaction Helps Find Targets for Antiviral Drugs

News

In some ways, the Ebola virus operates like a vampire; only after it is politely invited in to a host cell does it take up the task of destroying everything in its path. In a new study researchers seek to elucidate quantitatively the biomechanical mechanism of Ebola-host cell interaction, providing potential new targets for antiviral drug development.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE